[1]
“Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study”, J of Skin, vol. 8, no. 2, p. s357, Mar. 2024, doi: 10.25251/skin.8.supp.357.